Viz HCM vs Fetal EchoScan
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 60/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Viz HCM focuses on detecting Hypertrophic Cardiomyopathy in patients using real-time ECG analysis and coordinating subsequent adult cardiac care. In contrast, Fetal EchoScan assists clinicians in the prenatal detection of congenital heart defects through AI-powered ultrasound screening of fetuses. Therefore, while both are cardiology AI tools, they serve different patient populations and diagnostic stages.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
Viz HCM is an AI tool designed to detect suspected Hypertrophic Cardiomyopathy (HCM) in adults by analyzing real-time ECGs. Fetal EchoScan, on the other hand, is AI-powered ultrasound software that assists in the prenatal detection of congenital heart defects (CHDs) in fetuses.
Viz HCM analyzes real-time electrocardiogram (ECG) data to identify patterns suggestive of HCM. Fetal EchoScan uses AI to provide real-time guidance and feedback during prenatal ultrasound scans to detect CHDs.
Viz HCM is a cloud-based platform that integrates with hospital IT systems, including Electronic Health Records (EHR) and Picture Archiving and Communication Systems (PACS). Fetal EchoScan is a cloud-based software-only device that integrates seamlessly with existing ultrasound machines and reporting solutions, including DICOM, and offers a cart-side tablet display for real-time analysis.
Viz HCM has CMS reimbursement available for CPT codes 0764T and 0765T, with a national payment rate of $128.90, effective January 1, 2025. For Fetal EchoScan, pricing details are not publicly available, and physicians need to contact the vendor directly for pricing information.
Viz HCM is designed for Cardiology, Emergency Medicine, and Hospital Medicine, focusing on expediting HCM diagnosis and care coordination. Fetal EchoScan is intended for Cardiology, Maternal-Fetal Medicine, and Radiology, assisting in comprehensive prenatal congenital heart defect screening.
Viz HCM reduces time to diagnosis and treatment for HCM by providing real-time detection from ECGs and mobile alerts to multidisciplinary care teams, streamlining cardiac care coordination. Fetal EchoScan ensures exam completeness and standardization of fetal heart assessments, optimizes workflow, and aims to reduce false-negative and false-positive errors in CHD detection during prenatal ultrasounds.
More Comparisons
Backers
Who funded each tool's parent company.